segunda-feira, 19 de março de 2012

A Successful and Sustainable Health System — How to Get There from Here — via NEJM

This is only a fragment of a very interesting essay on the current pitfalls of US health system, but one can see lessons to Brazil, as well. The entire text is worth a read.

In his famous essay on Tolstoy entitled “The Hedgehog and the Fox,” Isaiah Berlin compared a number of historical figures to one or the other animal. Foxes know many things, whereas the hedgehog knows one big thing. Tolstoy, concluded Berlin, was a fox masquerading as a hedgehog: although he believed that history demanded a unifying theme, he could not resist his tendency to see many threads rather than one big cord.
To achieve a successful and sustainable health system, we must be able and willing to try many different things. But therein lies a unifying idea: do many things. No single stroke will solve this problem. A successful and sustainable health system will not be achieved by supporting prevention, it will not be achieved by championing competition, it will not be achieved by comparing the effectiveness of different practices, it will not be achieved by striking commercial influence from professional decision making, it will not be achieved by changing the way we pay doctors, and it will not be achieved by just reengineering the system. It requires all these changes and more. We need the cleverness of the fox and the persistence of the hedgehog. We must be willing to adopt many strategies and use them to reach one big goal.

Sources of Inefficiency in U.S. Health Care

• Payment for wrong outputs (units of service rather than episode of illness, health outcomes, or covered lives)

• Financial incentives that reward inefficiency (complications or readmissions)

• Lack of price information and incentives for patients

• Indifference of providers to induced costs

• Dysfunctional competition rather than performance-based competition

• Lack of personal or professional ethos to care about societal costs of health care

• Failure to take full advantage of professional skills of nurses

• Lack of uniform systems and processes to ensure safe and high-quality care

• Uneven patient flows, resulting in overcrowding, suboptimal care, and waste

• Insufficient involvement of patients in decision making (as in end-of-life care)

• Insufficient attention to prevention, disparities, primary care, health literacy, population health, and long-term results

• Fragmented and uncoordinated delivery, without continuity of care

• Lack of information on resource costs, performance, comparative effectiveness, quality of care, and health outcomes

• Scientific uncertainty about effectiveness and cost, especially of newer tests and treatments

• Cultural predisposition to believe that more care is better

• Administrative complexity of coping with multiple forms, regimens, and requirements of different insurers

• Rewarding of inventors and entrepreneurs for possible performance advantage more than for significant savings in overall system cost

• Regulatory regime that can only retard and not accelerate innovation

• Insufficient reliance on competitive bidding for drugs and devices

• Distortions resulting from fraud, conflict of interest, and a dysfunctional malpractice system

Potential Uses of Health IT

• Personal medical records

• Personalized health reminders and follow-up

• Personal health, diet, and activity monitoring and motivation

• Pre-degree and continuing medical education

• Real-time clinical decision support

• Remote professional consultation and care

• Monitoring and advising of patients with chronic disease

• Quality assurance

• Performance assessment of providers and institutions

• Comparative outcomes research

• Matching of potential participants to clinical trials

• Monitoring for safety (or unanticipated benefits) of drugs, devices, diagnostic tests, surgery, and other treatments

• Enhanced peer-to-peer and professional–patient support

• Comparative health assessments across populations, communities, cities, and states

• Public health surveillance for disease outbreaks, environmental risks, and potential bioterrorism
Disclosure forms provided by the author are available with the full text of this article at

Source Information

From the Institute of Medicine, Washington, DC.
Address reprint requests to Dr. Fineberg at the Institute of Medicine, 500 Fifth St., NW, Washington, DC 20001.

Link to the full text:

A Successful and Sustainable Health System — How to Get There from Here — NEJM

Clique aqui!

2015 A.C. Camargo academic journals acesso aberto adverse drug reactions alergia alquilantes alto custo ambiente analgésicos anomalias vasculares anti-eméticos anti-helmínticos anti-histamínico antianêmicos antiangiogênico anticâncer anticoagulantes antifúngicos antiprotozoários antivirais artemisinina arXiv asma asthma atopia atualização aula aulas auto-arquivamento avastin avermectina bevacizumab biologicals bioRxiv Blogger brain tumor cancer cancerologia pediátrica Carlos Chagas carne vermelha cauterização Ceará child chronic fatigue syndrome ciência ciência brasileira ciências biológicas e da saúde cientistas influentes cirurgia CLI conselho internacional crime virtual CT scans Curtis Harris darbopoietina dermatite diabetes dieta disautonomia dislipidemias doença renal doenças cardíacas doenças parasitárias dor DPOC eczema editoras predatórias efeitos adversos eficácia ensino e pesquisa eritropoietina erlotinib ESA escleroterapia estatinas esteróides estilo de vida exercícios F1000Research farmacogenética farmacologia fatores de crescimento fibromialgia Figshare Fisiologia e Medicina fitness flu FMJ fosfoetanolamina fraude acadêmica fraude eletrônica genetics glioblastoma gliomas Google Books gordos green way Harald zur Hausen hemangiomas hemophagocytic lymphohistiocytosis horário imagem immunology imunossupressores imunoterapia infecção urinária inibidores de ECA inibidores tirosina-quinase iniciação científica insulina irracionalismo ivermectina Jeffrey Beall journal hijack Lectures lepra leucemia leukemia linfangiomas Mac OS X macrophage activation syndrome magrinhas mal-formações March for Science Marcha pela Ciência medicina personalizada meta-análise Milton Santos modelos monoclonais monoclonal antibody mortalidade morte mudança Mulliken neuro-oncologia neuroblastoma neurology ngram viewer Nobel Nobel em Medicina ou Fisiologia novas drogas novos tratamentos obesidade ômega 3 open access osteoporose Osvaldo Cruz pediatria pediatric cancer pediatric tumors pediatrics peer review PeerJ personalized medicine PET/CT pharmacogenetics pharmacological treatment pharmacology plágio política de C&T posters postprints predatory publishers Preprints pressão arterial prevenção progressista projeto de pesquisa propranolol próstata publicação publicação científica publicações publication pubmed Python quimioterapia radiation radioterapia rapamycin recidiva regressão espontânea resposta resultados retrospectiva revisão por pares risco Satoshi Ömura Scholarly Open Access science ScienceNOW seguimento selênio self-archiving sequestro de periódico científico serotonina SIDA sildenafil slides sobrevida sulfa suplementos survival tacerva targeted therapy temozolamida temozolomide terapia alternativa tireóide tratamento tuberculose tumores cerebrais tumores pediátricos vaccine vacina via dourada via verde vitamina E vitaminas William C. Campbell Youyou Tu

Postagens populares